ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,104Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 96

$2.37M Total Retail Price of All Prescriptions

Rank: 1 out of 96

610 Patients Receiving at Least One Drug in Part D
44%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 610 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 610 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 2,824 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$261 was the average price of a prescription from this provider, compared to $214 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 918 248 S3 1 5
GABAPENTIN 839 303 2 1
TOPIRAMATE 374 34 3 6
TIZANIDINE HCL 342 52 4 10
CARISOPRODOL 330 35 R 5 34
ZOLPIDEM TARTRATE 320 90 6 19
CARBIDOPA-LEVODOPA 262 218 7 3
COPAXONE 235 73 8 32
LEVETIRACETAM 188 66 9 2
DONEPEZIL HCL 184 141 10 4
CYCLOBENZAPRINE HCL 173 32 R 11 31
LYRICA 169 41 12 9
CYMBALTA 166 29 13 13
CITALOPRAM HBR 163 61 14 30
SERTRALINE HCL 142 47 15 35
BACLOFEN 139 33 16 11
SUMATRIPTAN SUCCINATE 134 18 17 28
PRAMIPEXOLE DIHYDROCHLORIDE 121 55 18 23
TRAMADOL HCL 121 28 18 24
LAMOTRIGINE 105 0 20 8
AMPHETAMINE SALT COMBO 100 0 S2 21 64
FLUOXETINE HCL 98 13 22 51
NAMENDA 87 65 23 7
PYRIDOSTIGMINE BROMIDE 85 47 24 83
EXELON 84 81 25 18
TRAZODONE HCL 81 12 26 36
PROMETHAZINE HCL 80 0 R 27 44
PREDNISONE 79 20 28 57
FENTANYL 77 0 S2 29 33
MELOXICAM 76 16 30 41
VENLAFAXINE HCL ER 76 26 30 45
CARBAMAZEPINE 74 20 32 17
OXCARBAZEPINE 72 30 33 26
REBIF 69 26 34 68
DIVALPROEX SODIUM 69 20 34 29
GALANTAMINE HBR 69 44 34 54
PHENYTOIN SODIUM EXTENDED 69 23 34 16
ROPINIROLE HCL 66 37 38 22
RANITIDINE HCL 65 0 39 96
AMITRIPTYLINE HCL 61 0 R 40 20
OXYCODONE-ACETAMINOPHEN 58 17 S2 41 38
ESCITALOPRAM OXALATE 58 27 41 53
OXYCODONE HCL-ACETAMINOPHEN 54 29 S2 43 37
MIRTAZAPINE 53 29 44 56
GILENYA 52 0 45 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.